Tag: Cancer immunotherapy

August 10, 2026

CD19 CAR T Cells Persist for 10 Years in Lymphoma Patients

August 3, 2026

Newly Discovered Protein Acts as Off Switch for Human Immune Cells

July 30, 2026

New Ultrasound Technique Breaches Blood-Brain Barrier to Treat Gliomas

June 25, 2026

Teclistamab + Daratumumab/Lenalidomide Shows Deep Responses in Newly Diagnosed Multiple Myeloma: Phase 2 MajesTEC-5 Trial Insights

April 21, 2026

Ciltacabtagene Autoleucel CAR T Therapy for High-Risk Smoldering Multiple Myeloma

April 9, 2026

Synthetic Super-Enhancers Enable Precision Viral Immunotherapy

January 28, 2026

Neoadjuvant Ipilimumab Nivolumab Melanoma Survival Biomarkers

January 16, 2026

Neoantigen Vaccine for Lynch Syndrome Cancer Prevention: Phase 1b/2 Trial Results

January 13, 2026

Linavonkibart Pembrolizumab: Advanced Solid Tumors Trial

December 20, 2025

Immune System Rejuvenation: MIT Study on Mice

November 24, 2025

Therapeutic Peptide Vaccine for Fibrolamellar HCC – Phase 1 Trial

November 14, 2025

Liquid Biopsy-Guided Adjuvant Therapy in Bladder Cancer

October 19, 2025

Perioperative Pembrolizumab, Trastuzumab & FLOT in HER2+ Esophageal Cancer

September 29, 2025

Genomic-Matched Therapy in Advanced Solid Tumors: ROME Trial Results

September 25, 2025

Neoadjuvant PD-1 LAG-3 Antibody Melanoma Trial Results

September 9, 2025

GD2-Targeting CAR T Cells in Neuroblastoma Clinical Trial